Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo Efficacy

Erik Lindström, Bengt von Mentzer, Ingrid Påhlman, Ingela Ahlstedt, Anna Uvebrant, Elin Kristensson, Rakel Martinsson, Anna Novén, Jennie de Verdier and Georges Vauquelin
Journal of Pharmacology and Experimental Therapeutics September 2007, 322 (3) 1286-1293; DOI: https://doi.org/10.1124/jpet.107.124958
Erik Lindström
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bengt von Mentzer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingrid Påhlman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingela Ahlstedt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Uvebrant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elin Kristensson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rakel Martinsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Novén
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennie de Verdier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georges Vauquelin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 322 no. 3 1286-1293
DOI 
https://doi.org/10.1124/jpet.107.124958
PubMed 
17575073

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received April 27, 2007
  • Accepted June 14, 2007
  • Published online August 20, 2007.

Article Versions

  • Earlier version (June 15, 2007 - 11:30).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Erik Lindström,
  2. Bengt von Mentzer,
  3. Ingrid Påhlman,
  4. Ingela Ahlstedt,
  5. Anna Uvebrant,
  6. Elin Kristensson,
  7. Rakel Martinsson,
  8. Anna Novén,
  9. Jennie de Verdier and
  10. Georges Vauquelin
  1. AstraZeneca R&D, Mölndal, Sweden (E.L., B.v.M., I.P., I.A., A.U., E.K., R.M., A.N., J.d.V.); and Department of Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Brussels, Belgium (G.V.)
  1. Address correspondence to:
    Dr. Bengt von Mentzer, Astra Zeneca, Molecular Pharmacology, Kärragatan 5, 431 83 Mölndal, Sweden. E-mail: bengt.mentzer{at}astrazeneca.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: June 2007 to March 2023

AbstractFullPdf
Jun 2007500100
Jul 200716091
Aug 20078123114
Sep 2007342672
Oct 2007291641
Nov 2007101525
Dec 200711720
Jan 2008141030
Feb 2008131526
Mar 20089819
Apr 2008111521
May 200835324
Jun 2008201530
Jul 2008171020
Aug 2008171115
Sep 2008141519
Oct 2008191414
Nov 2008122025
Dec 200841613
Jan 2009161221
Feb 2009111520
Mar 2009202731
Apr 2009122131
May 20092918
Jun 20096618
Jul 200951421
Aug 200961511
Sep 200961519
Oct 2009101515
Nov 20095715
Dec 2009915
Jan 2010131114
Feb 2010301017
Mar 2010151026
Apr 2010101517
May 20101879
Jun 201091823
Jul 20101219
Aug 2010111216
Sep 201012839
Oct 2010132427
Nov 20109918
Dec 201010714
Jan 201181720
Feb 201122821
Mar 201161610
Apr 2011151118
May 2011111117
Jun 2011191117
Jul 20119716
Aug 20111489
Sep 20117712
Oct 2011141719
Nov 2011191419
Dec 2011667
Jan 20121298
Feb 201292322
Mar 2012131216
Apr 2012132323
May 20129812
Jun 201291211
Jul 2012101713
Aug 2012212030
Sep 2012151021
Oct 2012171221
Nov 2012161319
Dec 201251313
Jan 201361623
Feb 2013141514
Mar 201311918
Apr 2013201214
May 2013221312
Jun 2013101413
Jul 20131957
Aug 20136169
Sep 2013111616
Oct 20131077
Nov 2013112714
Dec 201312137
Jan 201424911
Feb 2014102113
Mar 201417129
Apr 2014171513
May 201452413
Jun 2014111820
Jul 2014153211
Aug 201441214
Sep 2014599
Oct 201491611
Nov 201471110
Dec 20147145
Jan 20159107
Feb 2015277
Mar 20159118
Apr 201561816
May 2015101912
Jun 201541212
Jul 201541812
Aug 201561324
Sep 201581014
Oct 20156116
Nov 2015131610
Dec 20154149
Jan 2016211113
Feb 2016131113
Mar 2016231218
Apr 201610209
May 20169118
Jun 2016151831
Jul 201691342
Aug 201681330
Sep 201631727
Oct 20160204
Nov 201652410
Dec 201651112
Jan 20173133
Feb 201753913
Mar 20171185
Apr 20173910
May 20171126
Jun 2017596
Jul 2017185
Aug 20170136
Sep 20172122
Oct 201781113
Nov 201701197
Dec 201712516
Jan 2018017612
Feb 2018317013
Mar 201817616
Apr 2018212625
May 201801114
Jun 20181776
Jul 201814424
Aug 201811910
Sep 201812816
Oct 201837914
Nov 2018211423
Dec 201854125
Jan 20194928
Feb 20194614
Mar 20192826
Apr 2019623
May 20192043
Jun 2019925
Jul 20191611
Aug 20192205
Sep 20191317
Oct 2019526
Nov 20193337
Dec 2019901
Jan 20202633
Feb 20201821
Mar 20201115
Apr 20202053
May 20201012
Jun 20202424
Jul 20202845
Aug 20201415
Sep 20201211
Oct 20201123
Nov 20201428
Dec 20201602
Jan 20211075
Feb 20211966
Mar 202135712
Apr 20211756
May 20211654
Jun 2021654
Jul 20211222
Aug 2021938
Sep 20211473
Oct 2021750
Nov 20212144
Dec 20213845
Jan 20221717
Feb 20223864
Mar 20222642
Apr 20221829
May 20222123
Jun 20221641
Jul 20221510
Aug 202242612
Sep 20222533
Oct 20221975
Nov 20221988
Dec 20221329
Jan 20232054
Feb 20232023
Mar 20231843

Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 385 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 385, Issue 1
1 Apr 2023
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo Efficacy
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo Efficacy

Erik Lindström, Bengt von Mentzer, Ingrid Påhlman, Ingela Ahlstedt, Anna Uvebrant, Elin Kristensson, Rakel Martinsson, Anna Novén, Jennie de Verdier and Georges Vauquelin
Journal of Pharmacology and Experimental Therapeutics September 1, 2007, 322 (3) 1286-1293; DOI: https://doi.org/10.1124/jpet.107.124958

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCELLULAR AND MOLECULAR

Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo Efficacy

Erik Lindström, Bengt von Mentzer, Ingrid Påhlman, Ingela Ahlstedt, Anna Uvebrant, Elin Kristensson, Rakel Martinsson, Anna Novén, Jennie de Verdier and Georges Vauquelin
Journal of Pharmacology and Experimental Therapeutics September 1, 2007, 322 (3) 1286-1293; DOI: https://doi.org/10.1124/jpet.107.124958
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Chlorogenic Acid Inhibits Breast Cancer Metastasis
  • SNAP25 and mGluRs Control Pathological Tau Release
  • N-Stearoylethanolamine Inhibits Platelet Reactivity
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics